Risau, 1997, Mechanisms of angiogenesis, Nature, 386, 671, 10.1038/386671a0
Papetti, 2002, Mechanisms of normal and tumor-derived angiogenesis, Am J Physiol Cell Physiol, 282, C947, 10.1152/ajpcell.00389.2001
Folkman, 1971, Tumor angiogenesis: therapeutic implications, N Engl J Med, 285, 1182, 10.1056/NEJM197111182852108
Weidner, 1991, Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma, N Engl J Med, 324, 1, 10.1056/NEJM199101033240101
Weidner, 1992, Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma 1, J Natl Cancer Inst, 84, 1875, 10.1093/jnci/84.24.1875
Riabov, 2014, Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis, Front Physiol, 5, 75, 10.3389/fphys.2014.00075
Korkaya, 2011, Breast cancer stem cells, cytokine networks, and the tumor microenvironment, J Clin Invest, 121, 3804, 10.1172/JCI57099
Wang, 2012, Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells, Stem Cell Res Ther, 3, 5, 10.1186/scrt96
D'Anello, 2010, Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells, Mol Cancer, 9, 300, 10.1186/1476-4598-9-300
Bharti, 2016, Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: a snapshot of IL-6 mediated involvement, Cancer Lett, 375, 51, 10.1016/j.canlet.2016.02.048
Ndlovu, 2009, Hyperactivated NF-kappa B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells, Mol Cell Biol, 29, 5488, 10.1128/MCB.01657-08
Nagasaki, 2014, Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction, Br J Cancer, 110, 469, 10.1038/bjc.2013.748
Li, 2003, IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis, J Immunol, 170, 3369, 10.4049/jimmunol.170.6.3369
Fràter-Schröder, 1987, Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo, Proc Natl Acad Sci U S A, 84, 5277, 10.1073/pnas.84.15.5277
Folkman, 2003, Fundamental concepts of the angiogenic process, Curr Mol Med, 3, 643, 10.2174/1566524033479465
Segal, 2009, Design and development of polymer conjugates as anti-angiogenic agents, Adv Drug Deliv Rev, 61, 1159, 10.1016/j.addr.2009.06.005
Davis, 2008, Nanoparticle therapeutics: an emerging treatment modality for cancer, Nat Rev Drug Discov, 7, 771, 10.1038/nrd2614
Satapathy, 2015, Enhancement of cytotoxicity and inhibition of angiogenesis in oral cancer stem cells by a hybrid nanoparticle of bioactive quinacrine and silver: implication of base excision repair cascade, Mol Pharm, 12, 4011, 10.1021/acs.molpharmaceut.5b00461
Mukherjee, 2005, Antiangiogenic properties of gold nanoparticles, Clin Cancer Res, 11, 3530, 10.1158/1078-0432.CCR-04-2482
Panyam, 2003, Biodegradable nanoparticles for drug and gene delivery to cells and tissue, Adv Drug Deliv Rev, 55, 329, 10.1016/S0169-409X(02)00228-4
Preet, 2012, Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity, Int J Cancer, 130, 1660, 10.1002/ijc.26158
Mohapatra, 2012, Quinacrine-mediated autophagy and apoptosis in colon cancer cells is through a p53- and p21-dependent mechanism, Oncol Res, 20, 81, 10.3727/096504012X13473664562628
Das, 2017, Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade, Oncotarget, 8, 248, 10.18632/oncotarget.11335
Guo, 2009, 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways, Oncogene, 28, 1151, 10.1038/onc.2008.460
Liang, 2008, Enhanced therapeutic effects on the multi-drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine, Fundam Clin Pharmacol, 22, 429, 10.1111/j.1472-8206.2008.00613.x
Edwards, 2007, Gold in a metallic divided state-from Faraday to present-day nanoscience, Angew Chem Int Ed Engl, 46, 5480, 10.1002/anie.200700428
Visvader, 2012, Cancer stem cells: current status and evolving complexities, Cell Stem Cell, 10, 717, 10.1016/j.stem.2012.05.007
Calabrese, 2007, A perivascular niche for brain tumor stem cells, Cancer Cell, 11, 69, 10.1016/j.ccr.2006.11.020
Sun, 2014, Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds, Biomaterials, 35, 836, 10.1016/j.biomaterials.2013.10.011
Wang, 2011, Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells, ACS Nano, 5, 3679, 10.1021/nn200007z
Wang, 2013, Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles, Biomaterials, 34, 4667, 10.1016/j.biomaterials.2013.03.008
Nayak, 2016, Nanoquinacrine induced apoptosis in cervical cancer stem cells through the inhibition of hedgehog-GLI1 cascade: Role of GLI-1, Sci Rep, 6, 20600, 10.1038/srep20600
Preet, 2014, Synthesis and biological evaluation of andrographolide analogues as anti-cancer agents, Eur J Med Chem, 85, 95, 10.1016/j.ejmech.2014.07.088
Chakraborty, 2014, Capsaicin-induced activation of p53-SMAR1 auto-regulatory loop down-regulates VEGF in non-small cell lung cancer to restrain angiogenesis, PLoS One, 9, e99743, 10.1371/journal.pone.0099743
Satapathy, 2015, The apoptotic effect of plant based nanosilver in colon cancer cells is a p53 dependent process involving ROS and JNK cascade, Pathol Oncol Res, 21, 405, 10.1007/s12253-014-9835-1
Chazotte, 2011, Labeling mitochondria with MitoTracker dyes, Cold Spring Harb Protoc, 2011, 990
Toth, 2012, Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography, Methods Mol Biol, 878, 121, 10.1007/978-1-61779-854-2_8
Mohapatra, 2014, The contribution of heavy metals in cigarette smoke condensate to malignant transformation of breast epithelial cells and in vivo initiation of neoplasia through induction of a PI3K-AKT-NFκB cascade, Toxicol Appl Pharmacol, 274, 168, 10.1016/j.taap.2013.09.028
Das, 2017, Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis, Apoptosis, 22, 1205, 10.1007/s10495-017-1400-4
Shin, 2015, Role of physicochemical properties in nanoparticle toxicity, Nanomaterials, 5, 1351, 10.3390/nano5031351
Korkaya, 2011, Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots, Clin Cancer Res, 17, 6125, 10.1158/1078-0432.CCR-10-2743
Naldini, 2005, Role of inflammatory mediators in angiogenesis, Curr Drug Targets Inflamm Allergy, 4, 3, 10.2174/1568010053622830
Reuter, 2010, Oxidative stress, inflammation, and cancer: how are they linked?, Free Radic Biol Med, 49, 1603, 10.1016/j.freeradbiomed.2010.09.006
Voronov, 2003, IL-1 is required for tumor invasiveness and angiogenesis, Proc Natl Acad Sci U S A, 100, 2645, 10.1073/pnas.0437939100
Yao, 2007, Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells, Int J Cancer, 121, 1949, 10.1002/ijc.22930
Fisman, 2010, The ubiquitous interleukin-6: a time for reappraisal, Cardiovasc Diabetol, 9, 62, 10.1186/1475-2840-9-62
Han, 2008, Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages, Arch Pharm Res, 31, 67, 10.1007/s12272-008-1122-9
Thakor, 2011, Gold nanoparticles: a revival in precious metal administration to patients, Nano Lett, 11, 4029, 10.1021/nl202559p
Sumbayev, 2013, Gold nanoparticles downregulate interleukin-1β-induced pro-inflammatory responses, Small, 9, 472, 10.1002/smll.201201528
Sullivan, 2009, Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells, Oncogene, 28, 2940, 10.1038/onc.2009.180
Gonzalez-Moreno, 2010, VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop, Exp Cell Res, 316, 554, 10.1016/j.yexcr.2009.11.020
Zhang, 2000, Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1, Proc Natl Acad Sci U S A, 97, 6427, 10.1073/pnas.97.12.6427
Yeh, 2000, The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest, Proc Natl Acad Sci U S A, 97, 12782, 10.1073/pnas.97.23.12782
Pan, 2014, Gold nanoparticles inhibit VEGF165-induced migration and tube formation of endothelial cells via the Akt pathway, Biomed Res Int, 2014, 418624, 10.1155/2014/418624
Roma-Rodrigues, 2016, Peptide-caoted gold nanoparticles for modulation of angiogenesis in vivo, Int J Nanomedicine, 11, 2633
Bharti, 2017, Somatostatin receptor targeted liposomes with diacerein inhibit IL-6 for breast cancer therapy, Cancer Lett, 388, 292, 10.1016/j.canlet.2016.12.021
Asharani, 2010, DNA damage and p53-mediated growth arrest in human cells treated with platinum nanoparticles, Nanomedicine (London), 5, 51, 10.2217/nnm.09.85
Mkandawire, 2015, Induction of apoptosis in human cancer cells by targeting mitochondria with gold nanoparticles, Nanoscale, 7, 10634, 10.1039/C5NR01483B
Deniaud, 2008, Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis, Oncogene, 27, 285, 10.1038/sj.onc.1210638
Butterworth, 2010, Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy, Nanotechnology, 21, 295101, 10.1088/0957-4484/21/29/295101